General Information
Revision date
2009-07-04
Product name
NALCLEAR 8173 P
Icons in SDS
Company Information
company name
Nalco Company
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW** CAUTION May cause irritation with prolonged contact. Do not get in eyes, on skin, on clothing. Do not take internally. Do not breathe dust. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. After contact with skin, wash immediately with plenty of soap and water. Avoid generating dusts. Wear suitable protective clothing. May form explosive dust-air mixtures. Handling operations may generate combustible dust in the finely divided and suspended state. To reduce the potential for dust explosions and/or fire, do not permit dust to accumulate. Empty product containers may contain product residue. Do not pressurize, cut, heat, weld, or expose containers to flame or other sources of ignition. May evolve oxides of carbon (COx) under fire conditions. May evolve oxides of nitrogen (NOx) under fire conditions.
Principle Routes of Exposure
Eye, Skin, Inhalation
Health hazards
ACUTE EYE CONTACT May cause irritation with prolonged contact. SKIN CONTACT May cause irritation with prolonged contact. Nalco Company 1601 W. Diehl Road « Naperville, Illinois 60563-1198 * (630)305-1000 For additional copies of an MSDS visit www.nalco.com and request access 1/11 C-83 INGESTION : Not a likely route of exposure. May be harmful if swallowed. INHALATION If dust is generated, can cause mucous membrane irritation. A single brief inhalation exposure (minutes) is not likely to cause serious effects. SYMPTOMS OF EXPOSURE : Acute A review of available data does not identify any symptoms from exposure not previously mentioned. Chronic A review of available data does not identify any symptoms from exposure not previously mentioned. AGGRAVATION OF EXISTING CONDITIONS : A review of available data does not identify any worsening of existing conditions. EMERGENCY TELEPHONE NUMBER(S) (800) 424-9300 (24 Hours) CHEMTREC - CHRONIC No adverse effects expected other than those mentioned above. 14.